Ads
related to: octreotide alternatives for diabetes treatment guidelines- Blood Sugar & A1C
Learn The Steps You Need To
Keep Your Blood Sugar Under Control
- How It Works
Manage Your A1C And Type 2 Diabetes
Discover A Treatment Option
- Patient Support
Get A Free 30 Minute Consultation
With A Certified Diabetes Educator
- Cardiovascular Risk
Learn About The Connection Between
Type 2 Diabetes & CV Risk
- Blood Sugar & A1C
explorepanel.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Patients were randomly assigned to receive either 177 Lu-DOTATATE and octreotide LAR at a dose of 30 mg every four weeks for symptom control (n=116) or to only receive octreotide LAR at a dose of 60 mg every four weeks (n=113, control group). In total, 200 out of the 231 patients entered long-term follow-up.
Octreotide is used for the treatment of growth hormone producing tumors (acromegaly and gigantism), when surgery is contraindicated, pituitary tumors that secrete thyroid-stimulating hormone (thyrotropinoma), [citation needed] diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in people with vasoactive intestinal peptide-secreting tumors ().
[4] [12] [14] [17] [27] Therapeutic alternatives with similar clinical performance are listed for some medicines and they may be considered for national essential medicines lists. [17] [18] The 9th Essential Medicines List for Children was updated in July 2023. [23] [28] Note: An α indicates a medicine is on the complementary list. [4] [14] [17]
All participants were required to follow diet and exercise recommendations, but the trials differed with respect to which other drugs participants were allowed to use for diabetes treatment. [4] In four trials, participants were randomly assigned to receive either bexagliflozin or placebo by mouth once daily. [ 4 ]
SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]
Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.
Ads
related to: octreotide alternatives for diabetes treatment guidelinesexplorepanel.com has been visited by 10K+ users in the past month